V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20056828 | 20086686 | 1.63 | 72.1 | Adjuvant (A) | null | 2019-03-02 | MITOMYCIN | N | N | DOCETAXEL | 100451694 |
| 20056919 | 20086687 | 1.51 | 58.6 | Palliative (P) | null | 2019-07-15 | CHOP R - 21 days | 01 | N | NOT MATCHED | 100071014 |
| 20056953 | 20086688 | 1.78 | null | Palliative (P) | 2017-01-23 | 2017-01-23 | FEC 100 | N | N | CISPLATIN + FLUOROURACIL + RT | 100253489 |
| 20057118 | 20086690 | 1.73 | 75.4 | 03 | 2016-08-01 | 2016-09-05 | Bevacizumab 5mg/kg | N | N | EVEROLIMUS | 101714926 |
| 20057123 | 20086691 | 1.61 | 58 | Adjuvant (A) | 2019-09-04 | 2019-09-12 | REGORAFENIB | 02 | N | SCOPE2 TRIAL | 100426505 |
| 20057164 | 20086692 | 1.59 | 95.55 | 03 | 2020-06-06 | 2020-06-09 | Hydroxycarbamide | 2 | N | EVEROLIMUS | 101859965 |
| 20057172 | 20086693 | 1.65 | 84.5 | Palliative (P) | 2018-10-23 | 2018-10-23 | Azacitidine | 02 | Y | GEMCITABINE + PACLITAXEL | 100983615 |
| 20057205 | 20086694 | 1.78 | 71.8 | 03 | 2019-02-05 | 2019-03-05 | ECarboX | N | N | FCIST | 101283420 |
| 20057274 | 20086695 | 1.88 | 45 | 03 | 2016-11-15 | 2016-12-04 | ANAGRELIDE | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101536904 |
| 20057415 | 20086697 | 1.74 | 69.6 | Palliative (P) | 2017-06-22 | 2017-07-03 | OXALIPLATIN | 01 | N | SUNITINIB | 101793798 |
| 20057432 | 20086698 | 1.8 | 79 | Palliative (P) | 2018-12-04 | 2019-01-06 | CHOP R - 21 days | N | N | CARBOPLATIN + PEMETREXED | 100510241 |
| 20057448 | 20086699 | 1.63 | 95.35 | 03 | 2017-07-26 | 2017-08-04 | Carbo F | 02 | N | GEMCARBO | 101130072 |
| 20057611 | 20086700 | 1.6 | 67.4 | 03 | 2019-06-26 | 2019-07-03 | ACELARATE Trial | 01 | N | PACLITAXEL | 100150645 |
| 20057634 | 20086701 | 1.7 | 64.4 | Palliative (P) | 2017-04-09 | 2017-04-09 | Hydroxycarbamide | 02 | N | FCARBOST | 100808277 |
| 20057665 | 20086703 | 1.61 | 59.8 | 03 | 2021-06-08 | 2021-06-29 | BALLAD Trial | N | N | IBRUTINIB | 101358573 |
| 20057736 | 20086704 | 0 | 0 | Curative (C) | null | 2020-09-10 | Bevacizumab + Oxaliplatin +MdG | 01 | N | BENDAMUSTINE + RITUXIMAB | 100898021 |
| 20057753 | 20086705 | 1.84 | 59 | 03 | 2018-04-23 | 2018-04-30 | CARBOPLATIN + FLUOROURACIL | 02 | N | MPV | 100900159 |
| 20057763 | 20086706 | 1.8 | 82 | 03 | 2019-08-13 | 2019-09-04 | SCOPE 2 TRIAL | null | N | IPILIMUMAB + NIVOLUMAB | 100114769 |
| 20057775 | 20086707 | 1.69 | 105.8 | 03 | null | 2017-05-24 | Rituximab | 02 | N | ESPAC TRIAL | 101763723 |
| 20057791 | 20086709 | 1.7 | 80 | 03 | 2018-07-29 | 2018-08-18 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100946727 |
| 20057799 | 20086710 | 1.78 | 74 | Adjuvant (A) | 2018-03-15 | 2018-04-12 | EEF or EOF | 01 | N | PACLITAXEL | 101209943 |
| 20057847 | 20086711 | null | null | null | 2016-01-13 | 2016-01-21 | Abiraterone | 01 | N | CAP + RT | 101212682 |
| 20057908 | 20086714 | 1.7 | 66.7 | Palliative (P) | null | 2019-01-12 | Raltitrexed | 01 | N | ANAGRELIDE | 101845807 |
| 20057909 | 20086715 | 1.52 | 50.9 | Adjuvant (A) | 2020-02-12 | 2020-02-14 | Cisplatin + Etoposide + RT | null | N | NEO-AEGIS TRIAL | 100725302 |
| 20057912 | 20086716 | 1.7 | 67.5 | Palliative (P) | 2018-02-23 | 2018-02-23 | SCOPE 2 TRIAL | 02 | N | SCOPE2 TRIAL | 100520475 |
| 20058008 | 20086717 | 1.77 | 77.8 | 03 | 2018-06-25 | 2018-06-28 | LOMUSTINE + PROCARBAZINE | 02 | N | BALLAD TRIAL | 101637630 |
| 20058021 | 20086718 | 1.71 | 93 | Palliative (P) | 2018-06-16 | 2018-06-16 | PEMBROLIZUMAB | 01 | N | GO2 TRIAL | 100094377 |
| 20058130 | 20086722 | 1.74 | 72 | 03 | 2019-07-10 | 2019-07-13 | ECarboX | N | N | MITOMYCIN | 101125683 |
| 20058137 | 20086723 | 1.75 | 86 | 03 | null | 2016-05-19 | Gemcitabine+Paclitaxel (Neo-tAnGo) | N | N | CHLORAMBUCIL | 100360452 |
| 20058138 | 20086724 | 1.74 | 59 | Palliative (P) | 2016-04-16 | 2016-04-16 | EVEROLIMUS | 02 | N | TOPOTECAN | 101470208 |
| 20058141 | 20086725 | 1.77 | 84.5 | Palliative (P) | 2020-04-28 | 2020-05-10 | NEO-AEGIS TRIAL | 02 | null | ECARBOX | 101057411 |
| 20058150 | 20086726 | 1.77 | 82.9 | Palliative (P) | null | 2016-08-11 | RUXOLITINIB | 1 | N | INCA TRIAL | 100008188 |
| 20058281 | 20086727 | null | 87.2 | Palliative (P) | null | 2019-03-06 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | EVEROLIMUS | 100139821 |
| 20058296 | 20086728 | 1.75 | 90 | 03 | 2019-08-21 | 2019-08-28 | SCOPE 2 TRIAL | 02 | Y | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101579814 |
| 20058343 | 20086729 | 1.66 | 60.05 | Palliative (P) | 2017-02-06 | 2017-02-06 | Capecitabine + Carboplatin + RT | 02 | N | PACLITAXEL | 101471062 |
| 20058372 | 20086730 | 1.72 | 105.1 | Curative (C) | 2019-01-12 | 2019-01-12 | EVEROLIMUS | 02 | Y | OXALIPLATIN | 100526255 |
| 20058411 | 20086731 | 1.6 | null | Palliative (P) | 2016-12-14 | 2016-12-19 | MIC | 02 | null | PACLITAXEL | 100973449 |
| 20058475 | 20086733 | 1.77 | 95.4 | null | 2019-03-11 | 2019-03-11 | Raltitrexed | 01 | N | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 100911196 |
| 20058550 | 20086735 | 1.81 | 80.9 | Palliative (P) | 2018-08-02 | 2018-08-11 | PEMBROLIZUMAB | 02 | N | DOXORUBICIN | 100802653 |
| 20058561 | 20086736 | 1.54 | 63.4 | Palliative (P) | 2016-10-26 | 2016-11-11 | ESHAP R | 02 | N | SCOPE2 TRIAL | 100556661 |
| 20058587 | 20086737 | 1.53 | 68 | Palliative (P) | 2018-01-21 | 2018-02-03 | FEC + DOCETAXEL | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101104895 |
| 20058599 | 20086738 | 1.85 | 58.6 | null | 2018-01-05 | 2018-01-07 | Ralitrexed | null | N | PEMBROLIZUMAB | 101581236 |
| 20058676 | 20086739 | 1.74 | 65.2 | Palliative (P) | 2018-05-20 | 2018-05-27 | TEMOZOLOMIDE | 01 | null | EOF | 100410283 |
| 20058712 | 20086740 | 0 | 8.5 | Palliative (P) | 2019-06-29 | 2019-06-30 | null | 02 | N | BORTEZOMIB + PANOBINOSTAT | 100407916 |
| 20058761 | 20086741 | 0 | 0 | 03 | 2016-07-21 | 2016-07-24 | FCarboSt | 02 | N | CARBOPLATIN + FLUOROURACIL | 100909921 |
| 20058800 | 20086742 | 1.67 | 74.1 | Palliative (P) | 2021-01-14 | 2021-01-17 | null | 02 | N | PACLITAXEL | 100879685 |
| 20058918 | 20086744 | 1.76 | 67.9 | Palliative (P) | 2017-09-02 | 2017-09-03 | CHOP R - 21 days | 02 | N | ARISTOTLE TRIAL | 101145093 |
| 20059090 | 20086745 | 1.78 | 91.2 | 03 | 2019-11-13 | 2019-12-30 | EC | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101331262 |
| 20059093 | 20086746 | 1.53 | 87.4 | Adjuvant (A) | 2016-03-23 | 2016-04-08 | IVA | 02 | null | RALTITREXED | 101346461 |
| 20059136 | 20086748 | 1.7 | 67.8 | Palliative (P) | 2016-09-30 | 2016-10-01 | Ixazomib + Lenalidomide | 01 | N | CARBOPLATIN + PEMETREXED | 101550392 |